6 results
diagnosis lupus rheumatology druginduced pediatrics sle comparison dermatology diabetes diabetic dil ebm erythematosus infusion ivfluids ketoacidosis monkeypox rates summary systemic
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018 https://www.nejm.org/doi/full/10.1056/NEJMoa1716816 Study
Clinical Trial of ... Infusion Rates for Pediatric ... NEJM 2018 https ... VisualAbstract #Peds ... #Pediatrics #DKA
Monkeypox What? Monkeypox virus belongs to the family Poxviridae, subfamily Chordopoxvirinae, and genus orthopoxvirus Viral zoonotic disease that is
disease that is caused ... Characteristic Rash ... three weeks Clinical ... Respiratory distress Treatment ... #Diagnosis #Management
Diabetic Ketoacidosis Management Priorities 1. Fluids 2. Insulin 3. Potassium 4. Acidosis 5. Re-establish oral fluids,
Ketoacidosis Management ... Identification and treatment ... an underlying cause ... #DKA #Diabetic ... #Pediatrics #Peds
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
40, F:M 9:1 • Clinical ... Manifestations: Malar rash ... Positive in 60-80% of cases ... - pANCA anti-MPO ... life-threatening • Treatment
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... - pANCA anti-MPO ... 40, F:M 9:1 • Clinical ... - pANCA anti-MPO
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... - pANCA anti-MPO ... Discontinuation of causal ... #management
No results found for "rash nejm peds causes management pediatric treatment clinical infant dka mpox"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #rash #nejm #peds #causes #management #pediatric #treatment #clinical #infant #dka #mpox